Balancing safety and efficacy: Factor XIa inhibitors vs. DOACs in atrial fibrillation: a systematic review and meta-analysis of randomised controlled trials
The efficacy and safety of edoxaban compared to warfarin in patients with atrial fibrillation with different clinical phenotypes: a meta-analysis of randomized controlled trials
Real-world outcomes of oral anticoagulation in atrial fibrillation patients with high bleeding and stroke risks: evidence from three international registries from Middle East, Europe and Asia-Pacific
Risk of adverse events in non-anticoagulated european and asian patients with atrial fibrillation and clinical complexity: an analysis from two prospective observational registries